4 articles
Sycamore Partners is reportedly selling Boots to Canada’s Weston family for $9bn, marking a return to the UK high street. The deal follows failed talks with Sigma Healthcare and highlights strong prof
Sigma Healthcare terminated preliminary talks to acquire UK pharmacy chain Boots, stating the deal would not meet its strategic and capital investment objectives.
Sycamore Partners negotiates $10 billion sale of UK pharmacy chain Boots with Weston family and Sigma Healthcare, cancelling planned London IPO.
British pharmacy chain Boots has appointed former Currys CEO Alex Baldock as its new leader ahead of a potential London IPO following a $10 billion buyout by Sycamore Partners.
ChemBrief